have a look at the company presentation where the bar graphs show recurring vs upfront income, not completely accurate but may help give you a rough idea. You’ll see a big jump in recurring after the hand over of EMS.
But don’t rely to heavily on it because EVS was also coming off the back of a heavy R&D phase so they would be naturally contributing to the recurring anyway at a similar point in time with their own push.
Im guessing you’re trying to see how much recurring they purchased vs naturally acquired?
like @Mr.Lumin said they are one and the same now going forward and there are really good synergies, plus evs has always targeted a recurring model of income even prior to Ems so it’s not like they just purchased a book of trail income and don’t know how to run it efficiently, so personally I think the concern there is minimal.
- Forums
- ASX - By Stock
- Ann: Appendix 4E & Annual Report to shareholders
EVS
envirosuite limited
Add to My Watchlist
1.19%
!
8.3¢

have a look at the company presentation where the bar graphs...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.3¢ |
Change
-0.001(1.19%) |
Mkt cap ! $120.9M |
Open | High | Low | Value | Volume |
8.4¢ | 8.4¢ | 8.3¢ | $110.6K | 1.327M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1125246 | 8.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.4¢ | 2758887 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1125246 | 0.083 |
4 | 2366528 | 0.082 |
2 | 760300 | 0.081 |
2 | 850000 | 0.080 |
2 | 706300 | 0.079 |
Price($) | Vol. | No. |
---|---|---|
0.084 | 2758887 | 5 |
0.085 | 1803954 | 13 |
0.086 | 2406398 | 8 |
0.087 | 826175 | 6 |
0.088 | 3211375 | 5 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
EVS (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online